SignaCor
SignaCor is a clinical-stage biotech platform exploring therapeutics for cardiac disorders, specifically hypertrophic cardiomyopathy
Country
Email Address
info@signacor.co.uk
Founded Date
2024
Founder
Headquarters
Industry
Investors
Latest Funding Round Date
March 9, 2026
Latest Funding Round Amount (USD)
330,000
Latest Funding Type
LinkedIn URL
Number of Employees (Ranges)
1 – 10
Total Funding Amount (USD)
330,000
Official Website
Find more companies like SignaCor
Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
By using this site, you agree to our Terms of Service.